EP0448704A4
Osteogenic devices
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 15 October 2010, 15.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both waysCites: the store holds 2 of 3
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| WO8909788A2 | Cites | World Intellectual Property Organization (WIPO) | XP | Search report |
| WO9011366A1 | Cites | World Intellectual Property Organization (WIPO) | XP | Search report |
| PROC. NATL. ACAD. SCI. USA, vol. 86, June 1989, pages 4554-4558; K. LYONS et al.: "Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor beta gene superfamily" | Non-patent | – | – | Search report |
| THE EMBO JOURNAL, vol. 9, no. 7, 1990, pages 2085-2093, Oxford University Press; E. ÖZKAYNAK et al.: "OP-1 cDNA encodes an osteogenic protein in the TGF-beta family" | Non-patent | – | – | Search report |
418 members in 16 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 42269989 | United States of America | A | |
| 42269989 | United States of America | A | |
| 48391390 | United States of America | A | |
| 48391390 | United States of America | A | |
| 56992090 | United States of America | A | |
| 56992090 | United States of America | A | |
| 9005903 | United States of America | W | |
| 9005903 | United States of America | W | |
| US19890422699 | – | – | – |
| US19900483913 | – | – | – |
| US19900569920 | – | – | – |
| WO1990US05903 | – | – | – |
Members418
| Document | Office | Kind | |
|---|---|---|---|
| WO8909787A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO8909788A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3444989A | Australia | A | |
| AU3530589A | Australia | A | |
| WO8909787A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO8909788A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0362367A1 | European Patent Office (EPO) | A1 | |
| EP0372031A1 | European Patent Office (EPO) | A1 | |
| US4943233A | United States of America | A | |
| WO9010018A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5174790A | Australia | A | |
| US4968590A | United States of America | A | |
| US4975526A | United States of America | A | |
| EP0411105A1 | European Patent Office (EPO) | A1 | |
| JPH03500655A | Japan | A | |
| CA2027259A1 | Canada | A1 | |
| CA2042577A1 | Canada | A1 | |
| US5011691A | United States of America | A | |
| WO9105802A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6648190A | Australia | A | |
| JPH03502579A | Japan | A | |
| EP0448704A1 | European Patent Office (EPO) | A1 | |
| JPH03504736A | Japan | A | |
| AU618357B2 | Australia | B2 | |
| CA2094027A1 | Canada | A1 | |
| JPH04502336A | Japan | A | |
| US5108753A | United States of America | A | |
| WO9207004A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9207073A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8900091A | Australia | A | |
| AU8941791A | Australia | A | |
| EP0411105A4 | European Patent Office (EPO) | A4 | |
| EP0448704A4This record | European Patent Office (EPO) | A4 | |
| AU627850B2 | Australia | B2 | |
| AU628050B2 | Australia | B2 | |
| CA2104678A1 | Canada | A1 | |
| CA2363965A1 | Canada | A1 | |
| WO9215323A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1754392A | Australia | A | |
| US5162114A | United States of America | A | |
| US5171574A | United States of America | A | |
| US5182365A | United States of America | A | |
| CA2116560A1 | Canada | A1 | |
| CA2116562A1 | Canada | A1 | |
| WO9304692A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9305172A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2116559A1 | Canada | A1 | |
| WO9305751A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2564592A | Australia | A | |
| AU2862492A | Australia | A | |
| AU3176293A | Australia | A | |
| WO9305751A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5250302A | United States of America | A | |
| US5258494A | United States of America | A | |
| US5266683A | United States of America | A | |
| CA2138270A1 | Canada | A1 | |
| WO9325246A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0575555A1 | European Patent Office (EPO) | A1 | |
| AU4599793A | Australia | A | |
| CA2141554A1 | Canada | A1 | |
| CA2141555A1 | Canada | A1 | |
| CA2141556A1 | Canada | A1 | |
| WO9403075A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9403200A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9403600A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4795193A | Australia | A | |
| AU4797193A | Australia | A | |
| AU4995593A | Australia | A | |
| CA2144513A1 | Canada | A1 | |
| CA2144514A1 | Canada | A1 | |
| CA2144515A1 | Canada | A1 | |
| WO9406399A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9406420A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9406447A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9406449A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5129293A | Australia | A | |
| AU5129393A | Australia | A | |
| AU5162393A | Australia | A | |
| AU5290893A | Australia | A | |
| CA2147598A1 | Canada | A1 | |
| WO9410203A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU648997B2 | Australia | B2 | |
| AU5590094A | Australia | A | |
| EP0601106A1 | European Patent Office (EPO) | A1 | |
| EP0601129A1 | European Patent Office (EPO) | A1 | |
| EP0601135A1 | European Patent Office (EPO) | A1 | |
| US5324819A | United States of America | A | |
| JPH06506360A | Japan | A | |
| WO9410203A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9406420A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9406447A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9406449A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5344654A | United States of America | A | |
| CA2157387A1 | Canada | A1 | |
| WO9420539A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6358894A | Australia | A | |
| US5354557A | United States of America | A | |
| EP0575555A4 | European Patent Office (EPO) | A4 | |
| WO9403075A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JPH06510432A | Japan | A |
Showing 100 of 418
80 legal events, as 13 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Supplementary protection certificate expiredExpiredSPCE | SPCE | GB | |
| Expiry of rightR071 | R071 | DE | |
| Supplementary protection certificate lapsedLapsedSPCL | SPCL | SE | |
| Supplementary protection certificate (spc) lapsedLapsedCTFL | CTFL | DK | |
| Lapse of an spcLapsedSPCL | SPCL | AT | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Patent lapsedLapsedPRODUCT NAME: RECOMBINANT HUMAN OSTEOGENIC PROTEIN-1 : BMP-7; REGISTRATION NO/DATE: EU/1/01/179/001 20010517RE | RE | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Supplementary protection certificate entered into forceCTFE | CTFE | GB | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Ep patent expiredExpiredEUP | EUP | DK | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Discontinued because of reaching the maximum lifetime of a patentV4 | V4 | NL | |
| Spc grantedGrantedV457 | V457 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Delivery of the decision of grantV484 | V484 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | SE | |
| Supplementary certificate of protection granted (eec regulation of 18 june 1992)GrantedCY | CY | FR | |
| Supplementary protection certificate grantedGrantedGBCTFGSPC/GB01/050: 20020520, EXPIRES: 20151014CTFG | CTFG | GB | |
| Supplementary protection certificate grantedGrantedGBCTFGSPC/GB01/050: 20020520, EXPIRES: 20151014CTFG | CTFG | GB | |
| Grant for a certificate of protection (e-series)EEZF | EEZF | AT | |
| Application for supplementary protection certificate (spc) filedDKCTFF CA 2001 00033, 20010928, EXPIRES: 20151015CTFF | CTFF | DK | |
| Application filed for a certificate of protection (e-series)ESZA | ESZA | AT | |
| Be: grant of a complementary protection certificate2001C/042, EXPIRES: 20151015CCPV | CCPV | EP | |
| Supplementary protection certificate (spc) filedCP | CP | FR | |
| Grant of a supplementary protection certificateNLKC1 300062, 20101015, EXPIRES: 20151014KC1 | KC1 | NL | |
| Supplementary protection certificateLUCCP 90855, EXPIRES: 20151015CCP | CCP | LU | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Supplementary protection certificate (spc) grantedGrantedSPCG | SPCG | IT | |
| Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)FRCR 01C0046, 20011024CR | CR | FR | |
| Supplementary protection certificate filedGBCTFFSPC/GB2001/050: 20011106CTFF | CTFF | GB | |
| Application for a supplementary protection certificateNLAC1 300062, 20010927AC1 | AC1 | NL | |
| Application for supplementary protection certificate filedSPCF | SPCF | SE | |
| Supplementary protection certificate (spc) filedSPCF | SPCF | IT | |
| Supplementary protection certificate (spc) filedCP | CP | FR | |
| Application of spcV448 | V448 | DE | |
| No opposition during term of oppositionOpposition8364 | 8364 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Fr: translation filedET | ET | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication, DOCDB
- 0448704
- Publication, EPODOC
- EP0448704
- Application
- 916655
- Application, DOCDB
- 90916655
- Application, EPODOC
- EP19900916655
Titles
- English
- OSTEOGENIC DEVICES
Classification
- CPC, 11
- C07K14/51
- A61C8/0006
- A61F2310/00365
- A61K38/00
- A61L27/227
- A61L27/24
- A61L27/34
- A61L27/3608
- A61L2430/02
- A61P19/00
- A61P43/00
- IPC, 20
- C12N15 09
- A61C8 00
- A61F2 00
- A61F2 28
- A61K38 00
- A61K48 00
- A61L27 00
- A61L27 22
- A61L27 24
- A61L27 34
- A61L27 36
- A61P19 00
- A61P43 00
- C07K1 20
- C07K14 435
- C07K14 51
- C07K16 18
- C07K17 02
- C12P21 02
- C12R1 91
Designated states1
- Contracting states, 1
- Sweden